Baugher Joshua Scott 4

Accession 0001415889-25-012112

CIK 0000100591other

View on SEC.gov Company Profile

Filed

May 5, 8:00 PM ET

Accepted

May 6, 5:16 PM ET

Size

21.7 KB

Accession

0001415889-25-012112

Insider Transaction Report

Form 4

Period: 2025-04-16

ARGAN INCAGX

Baugher Joshua Scott

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2025-04-16+538→ 913 total
Award
Option to Purchase Common Stock
2025-04-16$148.72/sh+1,000$148,720→ 2,500 total
Exercise: $148.72From: 2026-04-16Exp: 2035-04-16→ Common Stock (1,000 underlying)
Award
Performance-Based Restricted Stock Units
2025-04-16+1,500→ 1,500 total
Exercise: $0.00→ Common Stock (1,500 underlying)
Exercise/Conversion
Common Stock
2025-04-17+322→ 1,235 total
Exercise/Conversion
Time-Based Restricted Stock Units
2025-04-16−1,000→ 3,167 total
Exercise: $0.00→ Common Stock (1,000 underlying)
Award
Time-Based Restricted Stock Units
2025-04-16+2,000→ 5,167 total
Exercise: $0.00→ Common Stock (2,000 underlying)
Exercise/Conversion
Time-Based Restricted Stock Units
2025-04-17−583→ 4,584 total
Exercise: $0.00→ Common Stock (583 underlying)
Award
Earnings Per Share Performance-Based Restricted Stock Units
2025-04-16+3,750→ 3,750 total
Exercise: $0.00→ Common Stock (3,750 underlying)

Footnotes (6)

[F1]Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 1,000 shares of Common Stock became issuable to the Reporting Person on April 16, 2025.
[F2]Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 583 shares of Common Stock became issuable to the Reporting Person on April 17, 2025.
[F3]On April 16, 2025, the Reporting Person was granted TRSUs covering 2,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026.
[F4]On April 16, 2025, the Reporting Person received 10-year options to purchase 1,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026.
[F5]On April 16, 2025, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 1,500 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 1,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period.
[F6]On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,750 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 3,750 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period.

Documents

1 file

4
form4-05062025_090523.xmlPrimary

Issuer

ARGAN INC

CIK 0000100591

→

Entity typeother

Related Parties

filerCIK 0002066213

Filing Metadata

Form type: 4
Filed: May 5, 8:00 PM ET
Accepted: May 6, 5:16 PM ET
Size: 21.7 KB

View on SEC.gov